Bruker Corporation (NASDAQ:BRKR) reported preliminary revenue Friday for the first quarter that ended March 31, 2025, of $795 million to $800 million compared to a consensus of $758.85 million.
The company’s sales reflect around 10-11% year-over-year increase from $721.70 million.
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research and industrial and applied analysis.
This estimated range implies a reported revenue growth of approximately 10% year over year, with low double-digit percentage constant exchange rate revenue growth.
Bruker estimates adjusted organic revenue growth in the first quarter to …